Skip to main content

Paula Garcia Rodriguez

Institutions of which they are part

Research technician
Neurovascular Diseases
Vall Hebron Institut de Recerca

Paula Garcia Rodriguez

Institutions of which they are part

Research technician
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Malalties neurovasculars

IP: Anna Rosell Novel
Collaborators: Mercedes Arrue Gonzalo, Joan Montaner Villalonga, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Anna Bonaterra Pastra, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Antonio Palasi Franco, Jesús Pizarro Gonzálvez, Paula Garcia Rodriguez, Miguel García Gabilondo, Nicolas Garcia Rodriguez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00656
Duration: 01/01/2022 - 31/12/2024

Tratamientos endovasculares de neuroprotección y neuroreparación en la recuperación del ictus.

IP: Anna Rosell Novel
Collaborators: Anna Penalba Morenilla, Paula Garcia Rodriguez, Miguel García Gabilondo
Funding agency: Instituto de Salud Carlos III
Funding: 141570
Reference: PI22/01055
Duration: 01/01/2023 - 31/12/2025

MULTI-BIO-TARGETS: una nueva estrategia para el manejo de ictus combinando biomarcadores pronósticos y neuroprotectores

IP: Olga Maisterra Santos
Collaborators: Joan Montaner Villalonga, Anna Penalba Morenilla, Paula Garcia Rodriguez
Funding agency: Instituto de Salud Carlos III
Funding: 363907.5
Reference: PI18/00804
Duration: 01/01/2019 - 30/06/2023

PROOF: Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

IP: Joan Montaner Villalonga
Collaborators: Estela Sanjuan Menendez, Anna Penalba Morenilla, Tamara Del Rio Higueras, Ariadna Martín Balcells, Olalla Pancorbo Rosal, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Marcel Lamana Vallverdu, Paula Garcia Rodriguez
Funding agency: EUROPEAN COMMISSION
Funding: 715274.5
Reference: PROOF_H2020PHC2016/MONTANER
Duration: 01/01/2017 - 30/06/2023

Related news

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

The international study has identified 89 genes involved in the risk of developing a stroke, 61 of which had not been previously described.

Related professionals

Meri Montero Cueto

Meri Montero Cueto

Administrative
Accounting and Revenue Unit
Finances Area
Read more
Amina Coucous

Amina Coucous

Research assistant
Infectious Diseases
Read more
Maria Azucena Melgarejo Sanabria

Maria Azucena Melgarejo Sanabria

Administration and Management
Infectious Diseases
Read more
Florina Elena Tudorache

Florina Elena Tudorache

Maintenance staff and general services
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.